Tag: Altesa Biosciences Inc.

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...

FDA’s Accelerated Drug Review Plan Praised by Former Senior Trump Health Official

Brett P. Giroir M.D., Former Acting FDA Commissioner and Assistant Secretary for Health, Says New Commissioner's National Priority Voucher Program (CNPV) Can Help Speed...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsAltesa Biosciences Inc.

Kingworld Medicines Group (01110.HK) Signs MOU to Pursue Exclusive Distribution Rights for Two Lingnan Formula Products

Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives

We Mean Business Coalition: New polling shows overwhelming global business support for clean electrification amid fossil fuel volatility

Tag: Altesa Biosciences Inc.

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

FDA’s Accelerated Drug Review Plan Praised by Former Senior Trump Health Official

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us